• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference

    3/31/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care
    Get the next $MYO alert in real time by email

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer and David Henry, chief financial officer, will present at the 24th Annual Needham Virtual Healthcare Conference, being held from April 7th to April 10th, and will be holding one-on-one meetings with investors registered with the conference. The presentation will be webcast live at 3:00 p.m. ET on Thursday April 10th. The presentation will also be archived in the Investors section of the Company's website.

    Event:

    24th Annual Needham Virtual Healthcare Conference

    Date:

    Thursday, April 10, 2025

    Time:

    3:00 p.m. ET

    Webcast:

    Available here

    About Myomo

    Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250331633659/en/

    Myomo:

    [email protected]

    Alliance Advisors IR:

    Tirth T. Patel

    [email protected]

    212-201-6614

    Get the next $MYO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MYO

    DatePrice TargetRatingAnalyst
    7/31/2024$7.00Buy
    Craig Hallum
    5/20/2024$7.00Buy
    Lake Street
    12/15/2023$6.50Buy
    H.C. Wainwright
    More analyst ratings

    $MYO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Medical Officer Kovelman Harry covered exercise/tax liability with 13,054 shares, decreasing direct ownership by 8% to 140,618 units (SEC Form 4)

      4 - MYOMO, INC. (0001369290) (Issuer)

      7/2/25 8:20:13 AM ET
      $MYO
      Industrial Specialties
      Health Care
    • Chief Financial Officer Henry David A covered exercise/tax liability with 23,587 shares, decreasing direct ownership by 5% to 427,900 units (SEC Form 4)

      4 - MYOMO, INC. (0001369290) (Issuer)

      7/2/25 8:16:30 AM ET
      $MYO
      Industrial Specialties
      Health Care
    • Chief Medical Officer Kovelman Harry was granted 62,938 shares, increasing direct ownership by 69% to 153,672 units (SEC Form 4)

      4 - MYOMO, INC. (0001369290) (Issuer)

      6/13/25 5:14:09 PM ET
      $MYO
      Industrial Specialties
      Health Care